ARDELYX, INC. Current Assets
ARDELYX, INC. (ARDX) had Current Assets of $441.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $441.93M.
- 2026-03-31: Assets, Current $381.87M.
- 2025-12-31: Assets, Current $382.32M.
- 2025-09-30: Assets, Current $367.99M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $441.93M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $381.87M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $382.32M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $367.99M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $351.57M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $312.69M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $356.45M 10-K · filed 2026-02-19 |
| 2024-09-30 | $284.10M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $263.02M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $257.94M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $246.11M 10-K · filed 2025-02-20 |
| 2023-09-30 | $241.22M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $162.12M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $167.05M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $153.60M 10-K · filed 2024-02-22 |
| 2022-09-30 | $119.88M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $114.11M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $114.22M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $133.65M 10-K · filed 2023-03-02 |
| 2021-09-30 | $153.38M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $186.49M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $205.38M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $194.69M 10-K · filed 2022-02-28 |
| 2020-09-30 | $193.79M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $211.63M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $228.58M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $252.06M 10-K · filed 2021-03-08 |
| 2019-09-30 | $110.83M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $127.24M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $154.31M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $176.37M 10-K · filed 2020-03-06 |
| 2018-09-30 | $199.32M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $221.69M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $135.32M 10-Q · filed 2018-05-08 |
| 2018-01-02 | $5.00M 10-Q · filed 2018-11-07 |
| 2018-01-01 | $5.00M 10-K · filed 2019-03-06 |
| 2017-12-31 | $149.71M 10-K · filed 2019-03-06 |
| 2017-09-30 | $133.63M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $153.94M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $178.01M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $203.99M 10-K · filed 2018-03-14 |
| 2016-09-30 | $234.20M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $150.40M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $175.70M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $112.03M 10-K · filed 2017-02-17 |
| 2015-09-30 | $133.47M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $143.92M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $101.91M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $111.08M 10-K · filed 2016-03-04 |
| 2014-09-30 | $116.37M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $122.15M 10-Q · filed 2014-08-08 |
| 2013-12-31 | $41.84M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |